FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059855 [Registered on: 15/11/2023] Trial Registered Prospectively
Last Modified On: 06/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Post operative pain relief using Buprenorphine and Ketorolac 
Scientific Title of Study   A Randomized control study of post-operative analgesic effect of Buprenorphine and Ketorolac in elective abdomen surgeries under General Anaesthesia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kameshwar 
Designation  Post Graduate 
Affiliation  Srimuthukumaran Medical College 
Address  Department of Anesthesiology, SriMuthukumaran Medical College Hospital and Research Center,Mangadu, Chennai

Chennai
TAMIL NADU
600069
India 
Phone  9176191069  
Fax    
Email  speak2kamesh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ramkumar 
Designation  Associate professor 
Affiliation  Srimuthukumaran Medical College 
Address  Department of Anesthesiology, SriMuthukumaran Medical College Hospital and Research Center,Mangadu, Chennai

Chennai
TAMIL NADU
600069
India 
Phone  9840744672  
Fax    
Email  ramkumar.pal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Kameshwar 
Designation  Post Graduate 
Affiliation  Srimuthukumaran Medical College 
Address  Department of Anesthesiology,5thfloor, SriMuthukumaran Medical College Hospital and Research Center,Mangadu, Chennai

Chennai
TAMIL NADU
600069
India 
Phone  9176191069  
Fax    
Email  speak2kamesh@gmail.com  
 
Source of Monetary or Material Support  
Sri Muthukumaran Medical College Hospital and Research Institute. 
 
Primary Sponsor  
Name  Kameshwar ownself 
Address  Boys hostel, Sri Muthukumaran medical college, Mangadu, Chennai 600069 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kameshwar  Sri Muthukumaran Medical College Hospital and Research Institute  Department of Anesthesiology, 5th floor,
Chennai
TAMIL NADU 
9176191069

speak2kamesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K353||Acute appendicitis with localizedperitonitis, (2) ICD-10 Condition: K400||Bilateral inguinal hernia, with obstruction, without gangrene, (3) ICD-10 Condition: K811||Chronic cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Inj. Buprenorphine  4 micrograms/kg body weight intra muscular at the end of the surgery. One single dose 
Intervention  Inj. Ketorolac  0.9mg/kg body weight intra muscular at the end of surgery. One single dose. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA I or II
2. Patients scheduled for elective abdomen surgeries under general anesthesia
3. Age: 20-60 years
 
 
ExclusionCriteria 
Details  1. Patient refusal.
2. Allergy or hypersensitivity to Buprenorphine and Ketorolac.
3. Pregnant and Lactating women
4. Patient having
a. Uncontrolled hypertension/diabetes mellitus.
b. Cardiac disease, Hepatic diseases, renal diseases.
c. History of chronic pain.
d. Psychiatric disease.
e. Alcohol or drug usage.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Dose of the study drug
2. Time duration needed for the usage of rescue analgesic
 
Baseline ( before the surgery),
Intra operative period,
Immediate post operative period-0 minutes
1 hour after post operative period,
2 hours after post operative period,
4 hours after post operative period,
6 hours after post operative period,
8 hours after post operative period,
12 hours after post operative period.

 
 
Secondary Outcome  
Outcome  TimePoints 
Time duration for rescue analgesic  At the end of surgery 0 hours,
1 hour after surgery,
2 hours after surgery,
4 hours after surgery,
6 hours after surgery,
8 hours after surgery,
12 hours after surgery. 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Pain is a major post-operative complication worldwide, which impairs normal body performance and increases post-operative morbidity, hospitalization and susceptibility to infections which also can lead to chronic pain development.To compare the analgesic potential of Buprenorphine and Ketorolac for postoperative pain relief.

 
Close